2.14
price up icon5.42%   0.11
after-market Handel nachbörslich: 2.14
loading
Schlusskurs vom Vortag:
$2.03
Offen:
$2.06
24-Stunden-Volumen:
191.19K
Relative Volume:
1.20
Marktkapitalisierung:
$93.34M
Einnahmen:
$106.79M
Nettoeinkommen (Verlust:
$-8.73M
KGV:
-10.70
EPS:
-0.2
Netto-Cashflow:
$10.81M
1W Leistung:
+8.08%
1M Leistung:
-4.46%
6M Leistung:
-22.74%
1J Leistung:
-56.94%
1-Tages-Spanne:
Value
$2.05
$2.185
1-Wochen-Bereich:
Value
$1.953
$2.185
52-Wochen-Spanne:
Value
$1.95
$5.0759

Harvard Bioscience Inc Stock (HBIO) Company Profile

Name
Firmenname
Harvard Bioscience Inc
Name
Telefon
(508) 893-8999
Name
Adresse
84 OCTOBER HILL RD, HOLLISTON, MA
Name
Mitarbeiter
416
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
HBIO's Discussions on Twitter

Vergleichen Sie HBIO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
HBIO
Harvard Bioscience Inc
2.14 93.34M 106.79M -8.73M 10.81M -0.20
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
535.29 190.66B 7.87B 2.24B 586.00M 6.22
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
228.46 66.26B 20.18B 1.71B 3.07B 5.94
Medical Instruments & Supplies icon
ALC
Alcon Inc
84.06 41.58B 9.76B 1.16B 665.00M 2.34
Medical Instruments & Supplies icon
RMD
Resmed Inc
231.67 34.01B 4.81B 1.11B 1.35B 7.55
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
335.56 24.30B 2.88B 499.60M 321.60M 6.74

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-03-10 Hochstufung The Benchmark Company Speculative Buy → Buy
2021-01-07 Hochstufung The Benchmark Company Speculative Buy → Buy
2020-12-09 Eingeleitet Northland Capital Outperform
2020-11-10 Eingeleitet KeyBanc Capital Markets Overweight
2019-07-08 Herabstufung Janney Buy → Neutral
2018-01-24 Bestätigt Janney Buy
2018-01-23 Bestätigt The Benchmark Company Buy
2016-11-17 Eingeleitet Singular Research Buy
2015-07-28 Eingeleitet The Benchmark Company Buy
Alle ansehen

Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten

pulisher
Jan 02, 2025

State Street Corp Acquires 7,763 Shares of Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World

Jan 02, 2025
pulisher
Dec 27, 2024

HBIO stock touches 52-week low at $1.99 amid market challenges - Investing.com Nigeria

Dec 27, 2024
pulisher
Dec 18, 2024

Lexaria Bioscience Forms Elite Scientific Advisory Board with Harvard Medical School Expert - StockTitan

Dec 18, 2024
pulisher
Dec 17, 2024

Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience - Yahoo Finance

Dec 17, 2024
pulisher
Dec 17, 2024

BNP Paribas Financial Markets Has $201,000 Stock Holdings in Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World

Dec 17, 2024
pulisher
Dec 17, 2024

BNP Paribas Financial Markets Boosts Stock Position in Ovid Therapeutics Inc. (NASDAQ:OVID) - Defense World

Dec 17, 2024
pulisher
Dec 16, 2024

Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Update - Defense World

Dec 16, 2024
pulisher
Dec 13, 2024

Harvard Bioscience (HBIO) Stock Dips Amid Industry Movements - GuruFocus.com

Dec 13, 2024
pulisher
Dec 13, 2024

Harvard Bioscience (NASDAQ:HBIO) Stock Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat

Dec 13, 2024
pulisher
Dec 12, 2024

Harvard Bioscience (HBIO) Stock Drops Amid Market Volatility - GuruFocus.com

Dec 12, 2024
pulisher
Dec 09, 2024

3 US Penny Stocks With Market Caps Under $100M - Simply Wall St

Dec 09, 2024
pulisher
Dec 07, 2024

Harvard Bioscience files $100M mixed securities shelf - MSN

Dec 07, 2024
pulisher
Dec 03, 2024

In-Vitro and In-Vivo Micro Electrode Array Market to Grow by USD 7 Million (2024-2028), Driven by MEA Applications in Neuroscience Research, with AI Driving Market TransformationTechnavio - The Malaysian Reserve

Dec 03, 2024
pulisher
Dec 01, 2024

272 Capital LP Has $1.54 Million Position in Harvard Bioscience, Inc. (NASDAQ:HBIO) - MarketBeat

Dec 01, 2024
pulisher
Nov 22, 2024

Harvard Bioscience (HBIO) Stock Surges Amid Positive Analyst Rat - GuruFocus.com

Nov 22, 2024
pulisher
Nov 20, 2024

HBIO stock touches 52-week low at $1.99 amid market challenges By Investing.com - Investing.com South Africa

Nov 20, 2024
pulisher
Nov 18, 2024

Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Up 13.8% in October - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Ayla Majid becomes first South Asian ACCA president - The Accountant Online

Nov 18, 2024
pulisher
Nov 15, 2024

Harvard Bioscience (HBIO) Stock Drops Amid Industry Downturn - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

272 Capital LP Increases Stake in Harvard Bioscience Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 12, 2024

HBIO stock touches 52-week low at $2.29 amid market challenges - Investing.com India

Nov 12, 2024
pulisher
Nov 12, 2024

Harvard Bioscience (HBIO) Stock Dips Amid Market Volatility - GuruFocus.com

Nov 12, 2024
pulisher
Nov 11, 2024

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 11, 2024
pulisher
Nov 09, 2024

Harvard Bioscience Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 09, 2024
pulisher
Nov 08, 2024

Harvard Bioscience (HBIO) Stock Surges with Positive Analyst Rat - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Harvard Bioscience Inc (HBIO) Quarterly 10-Q Report - Quartzy

Nov 08, 2024
pulisher
Nov 08, 2024

SEC Form 10-Q filed by Harvard Bioscience Inc. - Quantisnow

Nov 08, 2024
pulisher
Nov 08, 2024

Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Call Highlights: Navigating Challenges and ... By GuruFocus - Investing.com Canada

Nov 08, 2024
pulisher
Nov 07, 2024

Harvard Bioscience: Q3 Earnings Snapshot - CT Insider

Nov 07, 2024
pulisher
Nov 07, 2024

Harvard Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

3 Promising US Penny Stocks With At Least $100M Market Cap - Simply Wall St

Nov 07, 2024
pulisher
Nov 07, 2024

Harvard Bioscience Inc Reports Q3 2024 Revenue of $22.0M, Misses Estimates; EPS Loss of $0.11 - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Harvard Bioscience : Q32024 HBIO Quarterly Earnings Presentation - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

Harvard Bioscience Announces Third Quarter 2024 Financial Results - GlobeNewswire

Nov 07, 2024
pulisher
Nov 06, 2024

Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Report Preview: W - GuruFocus.com

Nov 06, 2024
pulisher
Nov 06, 2024

Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance

Nov 06, 2024
pulisher
Nov 01, 2024

Is It Too Late To Consider Buying Harvard Bioscience, Inc. (NASDAQ:HBIO)? - Yahoo Finance

Nov 01, 2024
pulisher
Oct 31, 2024

Zacks Industry Outlook Highlights Mettler-Toledo International and Harvard Bioscience - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Harvard Bioscience (HBIO) Set to Announce Earnings on Thursday - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Moolec Science (MLEC) versus Its Rivals Head-To-Head Comparison - Defense World

Oct 30, 2024
pulisher
Oct 30, 2024

Chegg, Inc. (NYSE:CHGG) Receives Consensus Rating of “Reduce” from Brokerages - Defense World

Oct 30, 2024

Finanzdaten der Harvard Bioscience Inc-Aktie (HBIO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Harvard Bioscience Inc-Aktie (HBIO) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Green James W
Chief Executive Officer
Jun 06 '24
Buy
3.07
20,000
61,400
3,101,091
$21.76
price up icon 2.64%
medical_instruments_supplies BAX
$29.50
price up icon 0.82%
$208.26
price down icon 0.11%
$73.19
price up icon 2.02%
medical_instruments_supplies COO
$91.79
price up icon 1.25%
medical_instruments_supplies WST
$335.56
price up icon 2.18%
Kapitalisierung:     |  Volumen (24h):